Published • loading... • Updated
Xtant Medical Shares Surge 16% Following BioHorizons Deal to Distribute Prolifica in Dental Market
Summary by ts2.tech
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Xtant Medical Shares Surge 16% Following BioHorizons Deal to Distribute Prolifica in Dental Market
BELGRADE, Montana, August 28, 2026, 14:45 (MDT). Xtant Medical stock advanced 16% after BioHorizons agreed to introduce the Prolifica line to its dental sales channel, boosting access to the product in the dental sector. Xtant Medical finished the session at $0.384, rising 16.36%, with volume at 76.04 million shares.BioHorizons secures exclusive rights to distribute Xtant's…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
